Will domestic entry of Avastin make Roche worried?

Domestic clinical trials of biosimilars have been actively conducted towards ‘Avastin(generic name: bevacizumab),’ a VEGF(Vascular endothelial growth factor) targeted anticancer drug.

On the 5^th, Quintiles Transnational Korea acquired approval for the clinical trial of ‘BI 695502 concentrate for injection’ from the Ministry of Food and Drug Safety.

BI 695502 is an Avastin’s biosimilar that is...